Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 40

Sort by

Sort Order Select

Journal Articles

Limited Role of Workup Including PET-CT, Esophagogastroduodenoscopy and Bone Marrow Biopsy in Staging of Ocular Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT) Type

Heejung Chae, Cheolwon Suh, Dok Hyun Yoon, Jung Yong Hong, Chan-Sik Park, Jooryung Huh, Ho-Seok Sa, Kyoung Won Kim

Blood (2016) 128 (22): 2988.

https://doi.org/10.1182/blood.V128.22.2988.2988

Published: 2016

Journal Articles

Hematologists Should Order Endoscopic Examination to Specific Gastroenterologists Being Knowledgeable of Malignant Lymphoma in Case of Endoscopic Check-up of Gastrointestinal Malignant Lymphoma

Takuji Yamasaki, MD, PhD, Yuichi Yahagi, MD PhD

Blood (2016) 128 (22): 5342.

https://doi.org/10.1182/blood.V128.22.5342.5342

Published: 2016

Journal Articles

The spectrum of MALT lymphoma at different sites: biological and therapeutic relevance

Emanuele Zucca, Francesco Bertoni

Blood (2016) 127 (17): 2082–2092.

https://doi.org/10.1182/blood-2015-12-624304

Published: 2016

Journal Articles

AGMT MALT-2: A Phase II Study of Rituximab Plus Lenalidomide in Patients with Extranodal Marginal Zone B-Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue (MALT lymphoma)

Barbara Kiesewetter, MD, Richard Greil, MD, Wolfgang Willenbacher, MD, Peter Neumeister, MD, Michael A. Fridrik, MD, Raderer Markus, MD

Blood (2015) 126 (23): 3973.

https://doi.org/10.1182/blood.V126.23.3973.3973

Published: 2015

Journal Articles

Are Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) Occurring during the Course of Lymphoma (Ly) Always Therapy Related?

Camille Bigenwald, Stephanie Harel, Florian Chevillon, Damien Roos-Weil, Olivier A. Bernard, PhD, Sandy Amorim, MD, Pauline Brice, MD, Ades Lionel, Anne Marie Nloga, Marie Sébert, MD, Thorsten Braun, MD PhD, Virginie Eclache, Catherine Thieblemont, MDPhD, Pierre Fenaux, MD PhD

Blood (2015) 126 (23): 2886.

https://doi.org/10.1182/blood.V126.23.2886.2886

Published: 2015

Journal Articles

Phase II study of 90 y Ibritumomab Tiuxetan (Zevalin) in Patients with Previously Untreated Marginal Zone Lymphoma

Jesus C Fabregas, MD, James E. Hoffman, MD, Tulay Koru-Sengul, PhD, Miao Feng, Deborah Goodman, Aldo Serafini, MD, Peter J Hosein, MD, Alexandra Stefanovic, MD, Joseph D. Rosenblatt, MD, Izidore S. Lossos, MD

Blood (2014) 124 (21): 1762.

https://doi.org/10.1182/blood.V124.21.1762.1762

Published: 2014

Journal Articles

Antibiotic Therapy of H. Pylori Negative Gastric MALT Lymphoma

Seung Tae Lee, MD PhD, Purnima Teegavarupu, MD, Anusha Karri, Saswatha Anireddy, Fredrick B. Hagemeister, MD, Jorge E. Romaguera, MD, Luis Fayad, MD, Maria A. Rodriguez, MD, Felipe Samaniego, MD, Nathan Fowler, MD, Yasuhiro Oki, MD, Francesco Turturro, MD, Jason R. Westin, MD, Larry W Kwak, MD PhD, Bouthaina S. Dabaja, MD, Lei Feng, MS, R Eric Davis, MD, Sattva S Neelapu, MD

Blood (2014) 124 (21): 1735.

https://doi.org/10.1182/blood.V124.21.1735.1735

Published: 2014

Journal Articles

Munari F, Lonardi S, Cassatella MA, et al. Tumor-associated macrophages as major source of APRIL in gastric MALT lymphoma. Blood . 2011;117(24): 6612–6616 .

Blood (2012) 120 (22): 4447.

https://doi.org/10.1182/blood-2012-10-464446

Published: 2012

Journal Articles

Radiotherapy in Stage I and II Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT): Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database

Adam J. Olszewski, MD, Amrita Desai, MD, MPH

Blood (2012) 120 (21): 2053.

https://doi.org/10.1182/blood.V120.21.2053.2053

Published: 2012

Journal Articles

Final Results of a Multicenter Phase II Trial with Bendamustine and Rituximab As First Line Treatment for Patients with MALT Lymphoma (MALT-2008–01)

Antonio Salar, MD, Eva Domingo-Domenech, MD, Carlos Panizo, Concepción Nicolás, MD, Joan Bargay, Ana Muntanola, MD, Miguel Canales, Jose Luis Bello, MD, juan Manuel Sancho, Sr., MD, Jose Francisco Tomas, MD, María José Rodriguez, MD, Francisco-Javier Penalver, Luis Palomera, MD, Carlos Grande, José J Sánchez-Blanco, MD, Reyes Arranz, MD, Eulogio Conde, Dolores Caballero, MD, Carlos Montalban

Blood (2012) 120 (21): 3691.

https://doi.org/10.1182/blood.V120.21.3691.3691

Published: 2012

Journal Articles

Monoclonal B-Cell Lymphocytosis Exhibiting Immunophenotypic Features Consistent with Marginal Zone Origin: What Is This Entity?

Aliki Xochelli, Panagiotis Baliakas, Anne Gardiner, Sarah Mould, Zadie Davis, Neil McIver-Brown, Rachel Ibbotson, Evangelia Stalika, George Kanellis, Anastasia Athanasiadou, Achilles Anagnostopoulos, Theodora Papadaki, Kostas Stamatopoulos, David Oscier

Blood (2012) 120 (21): 1587.

https://doi.org/10.1182/blood.V120.21.1587.1587

Published: 2012

Journal Articles

Tumor-associated macrophages as major source of APRIL in gastric MALT lymphoma

Fabio Munari, Silvia Lonardi, Marco A. Cassatella, Claudio Doglioni, Maria Giulia Cangi, Amedeo Amedei, Fabio Facchetti, Yoshinobu Eishi, Massimo Rugge, Matteo Fassan, Marina de Bernard, Mario M. D'Elios, William Vermi

Blood (2011) 117 (24): 6612–6616.

https://doi.org/10.1182/blood-2010-06-293266

Published: 2011

Journal Articles

Kinetics of Regulatory T-Cells Are Highly Influenced by Treatment In Patients with Gastric MALT Lymphoma

Mar Garcia, Beatriz Bellosillo, Blanca Sanchez-González, Agustin Seoane, Luz Martínez-Avilés, Ana Ferrer, Eva Gimeno, Francesc Sole, Carlos Besses, Sergi Serrano, Antonio Salar

Blood (2010) 116 (21): 2003.

https://doi.org/10.1182/blood.V116.21.2003.2003

Published: 2010

Journal Articles

Chlorambucil Plus Rituximab Produces Better Event-Free Survival in Comparison with Chlorambucil Alone in the Treatment of MALT Lymphoma: 5-Year Analysis of the 2-Arms Part of the IELSG-19 Randomized Study

Blood (2010) 116 (21): 432.

https://doi.org/10.1182/blood.V116.21.432.432

Published: 2010

Journal Articles

A Newly Identified Translocation t(X;14)(p11;q32) In MALT Lymphoma Involving IGHS and GPR34 Reveals A Novel Role for GPR34 In Cell Growth and Tumor Development

Stephen M. Ansell, MD, PhD, Takashi Akasaka, MD, PhD, Michelle Manske, Tammy Price-troska, Steven Ziesmer, Esteban Braggio, Rafael Fonseca, Mamta Gupta, Ph.D, Mark E Law, Thomas E. Witzig, MD, Martin JS Dyer, MA, DPhil, FRCP, FRCPath, Ahmet Dogan, M.D., Ph.D., Anne J. Novak, PhD

Blood (2010) 116 (21): 1999.

https://doi.org/10.1182/blood.V116.21.1999.1999

Published: 2010

Journal Articles

Primary Pulmonary MALT Lymphoma: Clinical Characteristics and Treatment Outcomes – Single Institution Experience

Grzegorz S. Nowakowski, MD, Kay Ristow, Paul Kurtin, MD, Mark S Allen, Ivana N Micallef, MD, Joseph Colgan, David James Inwards, MD, Ellen McPhail, MD, Svetomir Markovic, MD, PhD, Stephen M. Ansell, MD, PhD, Luis Porrata, MD, Patrick B Johnston, MD, PhD, Carrie A Thompson, MD, Thomas E. Witzig, MD, Thomas M. Habermann, MD

Blood (2010) 116 (21): 4168.

https://doi.org/10.1182/blood.V116.21.4168.4168

Published: 2010

Journal Articles

Non-Gastric Advanced MALT Lymphoma Demonstrated Worse Prognosis Than Gastric MALT Lymphoma Even Treated by Rituximab-Combined chemotherapy.

Kyoko Ueda, MD, Yasuhito Terui, MD, PhD, Masahiro Yokoyama, MD, Sakura Sakajiri, Yuko Mishima, MD, Noriko Nishimura, MD, PhD, Kenji Nakano, Eriko Nara, Kazuhito Suzuki, Kentaro Nasu, Shunji Takahashi, MD, PhD, Kengo Takeutchi, MD, PhD, Kiyohiko Hatake, MD, PhD

Blood (2010) 116 (21): 2815.

https://doi.org/10.1182/blood.V116.21.2815.2815

Published: 2010

Journal Articles

Response: Gastric MALT lymphoma–derived tumor immunoglobulins are polyreactive and respond to a variety of self and foreign antigens

Vanessa J. Craig, Anne Müller

Blood (2010) 116 (10): 1819–1820.

https://doi.org/10.1182/blood-2010-05-278911

Published: 2010

Journal Articles

Gastric MALT lymphoma B cells express polyreactive, somatically mutated immunoglobulins

Vanessa J. Craig, Isabelle Arnold, Christiane Gerke, Minh Q. Huynh, Thomas Wündisch, Andreas Neubauer, Christoph Renner, Stanley Falkow, Anne Müller

Blood (2010) 115 (3): 581–591.

https://doi.org/10.1182/blood-2009-06-228015

Published: 2010

Includes: Supplemental data

Journal Articles

Interim Analysis of the IELSG-19 Randomised Study of Chlorambucil Alone Versus Chlorambucil Plus Rituximab Versus Rituximab Alone in Extranodal Marginal Zone Lymphomas of Mucosa-Associated Lymphoid Tissue (MALT lymphoma).

Blood (2009) 114 (22): 3939.

https://doi.org/10.1182/blood.V114.22.3939.3939

Published: 2009

NARROW

Limited Role of Workup Including PET-CT, Esophagogastroduodenoscopy and Bone Marrow Biopsy in Staging of Ocular Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT) Type

Hematologists Should Order Endoscopic Examination to Specific Gastroenterologists Being Knowledgeable of Malignant Lymphoma in Case of Endoscopic Check-up of Gastrointestinal Malignant Lymphoma

The spectrum of MALT lymphoma at different sites: biological and therapeutic relevance

AGMT MALT-2: A Phase II Study of Rituximab Plus Lenalidomide in Patients with Extranodal Marginal Zone B-Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue (MALT lymphoma)

Are Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML) Occurring during the Course of Lymphoma (Ly) Always Therapy Related?

Phase II study of 90 y Ibritumomab Tiuxetan (Zevalin) in Patients with Previously Untreated Marginal Zone Lymphoma

Antibiotic Therapy of H. Pylori Negative Gastric MALT Lymphoma

Munari F, Lonardi S, Cassatella MA, et al. Tumor-associated macrophages as major source of APRIL in gastric MALT lymphoma. Blood . 2011;117(24): 6612–6616 .

Radiotherapy in Stage I and II Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue (MALT): Analysis of the Surveillance, Epidemiology, and End Results (SEER) Database

Final Results of a Multicenter Phase II Trial with Bendamustine and Rituximab As First Line Treatment for Patients with MALT Lymphoma (MALT-2008–01)

Monoclonal B-Cell Lymphocytosis Exhibiting Immunophenotypic Features Consistent with Marginal Zone Origin: What Is This Entity?

Tumor-associated macrophages as major source of APRIL in gastric MALT lymphoma

Kinetics of Regulatory T-Cells Are Highly Influenced by Treatment In Patients with Gastric MALT Lymphoma

Chlorambucil Plus Rituximab Produces Better Event-Free Survival in Comparison with Chlorambucil Alone in the Treatment of MALT Lymphoma: 5-Year Analysis of the 2-Arms Part of the IELSG-19 Randomized Study

A Newly Identified Translocation t(X;14)(p11;q32) In MALT Lymphoma Involving IGHS and GPR34 Reveals A Novel Role for GPR34 In Cell Growth and Tumor Development

Primary Pulmonary MALT Lymphoma: Clinical Characteristics and Treatment Outcomes – Single Institution Experience

Non-Gastric Advanced MALT Lymphoma Demonstrated Worse Prognosis Than Gastric MALT Lymphoma Even Treated by Rituximab-Combined chemotherapy.

Response: Gastric MALT lymphoma–derived tumor immunoglobulins are polyreactive and respond to a variety of self and foreign antigens

Gastric MALT lymphoma B cells express polyreactive, somatically mutated immunoglobulins

Interim Analysis of the IELSG-19 Randomised Study of Chlorambucil Alone Versus Chlorambucil Plus Rituximab Versus Rituximab Alone in Extranodal Marginal Zone Lymphomas of Mucosa-Associated Lymphoid Tissue (MALT lymphoma).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only